Morphometric Study of the Female Pelvic and Lower Abdominal Retroperitoneum in Cadavers (NCT07522931) | Clinical Trial Compass
RecruitingNot Applicable
Morphometric Study of the Female Pelvic and Lower Abdominal Retroperitoneum in Cadavers
Spain20 participantsStarted 2026-04-14
Plain-language summary
This study aims to provide a systematic anatomical and morphometric description of the female pelvic and lower abdominal retroperitoneum using cadaveric dissection, with direct application to gynecologic surgery.
Standardized dissections will be performed in adult female cadavers obtained from a body donation program. Key anatomical structures, including the ureter, iliac vessels, aorta, inferior vena cava, hypogastric plexuses, and lymphatic territories, will be identified and measured. Spatial relationships, distances, and anatomical variations will be recorded using direct measurements and standardized photographic documentation.
The study will quantify anatomical variability and asymmetry between right and left hemipelves, focusing on ureteral, vascular, and neural structures. The results are expected to improve surgical planning, particularly in nerve-sparing techniques and pelvic and para-aortic lymphadenectomy, and to support the development of an applied anatomical atlas for educational and clinical use.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female cadavers from an institutional body donation program
* Age ≥ 18 years at time of death
* Adequate preservation of pelvic and abdominal retroperitoneal structures
* Anatomical integrity allowing identification of ureter, iliac vessels, hypogastric plexuses, aorta, and vena cava
* Availability of both hemipelves for comparative analysis
* Authorization for research use according to institutional body donation regulations
Exclusion Criteria:
* Male cadavers
* Prior major pelvic or abdominal surgery significantly altering retroperitoneal anatomy (e.g., hysterectomy, lymphadenectomy, vascular surgery)
* History of pelvic or abdominal radiotherapy
* Advanced pelvic or abdominal malignancy with retroperitoneal involvement
* Severe trauma affecting pelvic or abdominal anatomy
* Poor preservation or significant tissue degradation
* Absence of one or both hemipelves
* Advanced pregnancy at time of death
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Global Morphometric Characterization of the Female Pelvic and Lower Abdominal Retroperitoneum
Timeframe: Baseline
Trial details
NCT IDNCT07522931
SponsorHospital Universitari de Bellvitge
Sponsor typeOTHER
Study typeOBSERVATIONAL
Primary completion2026-09-28
Contact for this trial
Jorge Garcia Fernandez Principal Investigator, Gynecologist